Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma. [electronic resource]
Producer: 20010329Description: 389-97 p. digitalISSN:- 0732-183X
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cyclophosphamide -- administration & dosage
- Doxorubicin -- administration & dosage
- Drug Administration Schedule
- Female
- Genes, bcl-2
- Humans
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Middle Aged
- Polymerase Chain Reaction
- Prednisone -- administration & dosage
- Remission Induction
- Rituximab
- Survival Analysis
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.